CSL Behring Australia
The Associate Director, Hematology Commercial Development supports the development and execution of global commercial strategies for pipeline assets within the Hematology Therapeutic Area. This role combines strategic planning with structured project management to ensure timely delivery of commercialization milestones across cross-functional teams. The position involves partnering with R&D, Commercial, Market Access, and Medical Affairs to align on strategy and execution.
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL Behring Australia.
CSL Behring Australia didn’t post a salary, so this is our estimate from similar listings.
11% below the average for this role
Head of Early Assets, Hematology
AstraZeneca
Therapeutic Area Strategy Director, Oncology & Hematology
Novartis
Associate Director – Strategic Sourcing 'Business Development'
1080030P
Director, Neuroscience Pipeline Commercial Strategy - Neuroimmunology
AbbVie
Associate Marketing Manager
Baxter International
Senior Director, Portfolio Strategy and Governance - Hematology
BeOne Medicines